Open sidebar
Focus
Shionogi
Asia & Pacific
|
Ellen Wan
,
Angela Bright
Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint
Nov 18, 2022
|
Ellen Wan
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Nov 18
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
|
Reuters
Japan’s Shionogi Says COVID-19 Pill Shows Rapid Clearance of Virus
Apr 26, 2022
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Apr 26
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Markets News
|
Benzinga
Japan-Based Shionogi’s COVID-19 Drug Associated With Birth Defects: Bloomberg
Apr 14, 2022
|
Benzinga
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Apr 14
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Asia & Pacific
|
Reuters
Japan’s Shionogi Seeks Approval for COVID-19 Pill
Feb 26, 2022
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Feb 26
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Companies
|
Reuters
Japan’s Shionogi Starts Phase III Clinical Trial in Vietnam for COVID-19 Vaccine
Dec 27, 2021
|
Reuters
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email
Dec 27
|
Copy
Facebook
X
Truth
Gettr
LinkedIn
Telegram
Email